Roundup Weed Killer Lawsuit Overview
Roundup is a glyphosate-based herbicide originally developed by Monsanto and now manufactured by Bayer AG following its 2018 acquisition. For decades, Roundup has been the most widely sold weed killer in the world, used by homeowners, landscapers, farmers, and municipal groundskeepers. However, since the International Agency for Research on Cancer (IARC), a branch of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" in 2015, tens of thousands of lawsuits have been filed against Bayer alleging that prolonged Roundup exposure caused plaintiffs to develop non-Hodgkin lymphoma (NHL) and other cancers.
The Roundup litigation is one of the largest mass tort actions in United States history. As of 2026, Bayer has faced more than 100,000 claims and has paid billions of dollars in settlements and jury verdicts. Key trials in the multidistrict litigation (MDL) resulted in landmark plaintiff verdicts, including the landmark 2018 Johnson v. Monsanto case where a jury awarded $289 million to a school groundskeeper diagnosed with terminal NHL after years of Roundup use. Subsequent trials in Pilliod v. Monsanto and Hardeman v. Monsanto also produced substantial plaintiff verdicts, reinforcing the strength of the scientific and legal arguments linking glyphosate to cancer.
Despite Bayer's continued assertion that glyphosate is safe, the company has established multiple settlement programs totaling over $10 billion to resolve current and future claims. Courts have continued to allow new Roundup cancer cases to proceed, and legislative and regulatory developments at both state and federal levels may further shape the litigation landscape in 2026 and beyond. If you used Roundup products and have been diagnosed with non-Hodgkin lymphoma or another qualifying cancer, you may still have legal options available to pursue compensation for your medical expenses, lost income, pain and suffering, and other damages.
The Link Between Glyphosate and Cancer
The scientific debate surrounding glyphosate and cancer risk has been central to the Roundup litigation. In March 2015, the IARC reviewed extensive epidemiological studies, animal bioassays, and mechanistic data before classifying glyphosate as a Group 2A carcinogen, meaning it is "probably carcinogenic to humans." This classification was based on "sufficient evidence" of carcinogenicity in experimental animals and "limited evidence" in humans, with particular attention to associations with non-Hodgkin lymphoma observed in agricultural worker studies.
Multiple peer-reviewed studies have supported the association between glyphosate exposure and increased cancer risk. A 2019 meta-analysis published in the journal Mutation Research by researchers at the University of Washington found that individuals with the highest levels of glyphosate exposure had a 41% increased risk of developing NHL compared to those with no exposure. Other studies have examined genotoxic mechanisms, including oxidative stress and chromosomal damage, that could explain how glyphosate may promote cancer development at the cellular level.
Bayer and its supporters point to assessments by the U.S. Environmental Protection Agency (EPA) and the European Food Safety Authority (EFSA), which have generally concluded that glyphosate is "not likely to be carcinogenic to humans" at typical exposure levels. However, plaintiffs' attorneys have argued that these regulatory assessments relied heavily on industry-funded studies and did not adequately weigh the independent scientific literature. Internal Monsanto documents revealed during litigation — often referred to as the "Monsanto Papers" — suggested that the company engaged in ghostwriting scientific articles, sought to influence regulatory reviews, and attempted to discredit researchers whose work linked glyphosate to cancer.
The cancers most commonly linked to Roundup and glyphosate exposure include:
- Non-Hodgkin Lymphoma (NHL) — the most frequently alleged diagnosis in Roundup lawsuits, encompassing multiple subtypes
- Diffuse Large B-Cell Lymphoma (DLBCL) — an aggressive form of NHL and the most common subtype
- Follicular Lymphoma — a slower-growing NHL subtype
- Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
- Mantle Cell Lymphoma and other B-cell and T-cell lymphomas
Eligibility Criteria for a Roundup Lawsuit
Determining whether you may be eligible to file a Roundup weed killer lawsuit involves evaluating several key factors. While every case is unique and must be assessed on its individual merits, the following general criteria are typically considered by attorneys evaluating potential Roundup cancer claims:
-
1
Documented Roundup Exposure
You must be able to demonstrate that you had meaningful exposure to Roundup or other glyphosate-based herbicides. This may include home and garden use, occupational exposure as a landscaper, groundskeeper, or farmworker, or agricultural application on crops. Both the duration and frequency of exposure are relevant factors. Generally, cases involving regular use over a period of two or more years may be considered stronger, though shorter exposure periods do not necessarily disqualify a claim.
-
2
Qualifying Cancer Diagnosis
You must have been diagnosed with non-Hodgkin lymphoma or another cancer that scientific evidence has linked to glyphosate exposure. NHL and its subtypes — including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, and other B-cell or T-cell lymphomas — are the primary diagnoses pursued in Roundup litigation. Your diagnosis should be confirmed by medical records and pathology reports.
-
3
Temporal Relationship
Your cancer diagnosis should have occurred after a period of Roundup exposure. Establishing that the exposure preceded the diagnosis is a fundamental element of causation in toxic tort claims. The latency period between initial glyphosate exposure and cancer development may vary, often spanning several years or more.
-
4
Statute of Limitations
Your claim must be filed within the applicable statute of limitations, which varies by state. In most states, the statute of limitations for personal injury claims ranges from two to four years from the date of diagnosis or the date you reasonably should have known that your cancer may be related to Roundup use. Because deadlines differ significantly by jurisdiction, consulting with a qualified attorney promptly is essential to preserving your legal rights.
Family members of individuals who have passed away from cancers linked to Roundup exposure may also be eligible to file wrongful death claims. Surviving spouses, children, and other dependents could potentially seek compensation for funeral and burial costs, loss of financial support, loss of consortium, and other damages. An experienced Roundup attorney can evaluate the specific facts of your situation and advise you on the best course of action.
Bayer Roundup Settlement Updates (2026)
The Roundup settlement landscape has evolved significantly since the first major jury verdicts in 2018 and 2019. Bayer initially announced a sweeping $10.9 billion settlement framework in June 2020 to resolve approximately 75% of the roughly 125,000 filed and unfiled claims at that time. This remains one of the largest mass tort settlements in American legal history. The settlement framework established tiered compensation based on the severity of illness, strength of exposure evidence, and other case-specific factors.
Settlement amounts in Roundup cases have varied widely depending on the individual circumstances of each claim. While no specific amount is guaranteed, publicly reported data suggests the following general ranges:
- Tier 1 (most severe cases) — Claims involving death or advanced-stage NHL with strong exposure evidence have reportedly settled in the range of $100,000 to $250,000 or more per individual claim within the settlement program.
- Tier 2 (moderate cases) — Claims with confirmed NHL diagnosis and moderate exposure history have reportedly received settlements in lower ranges.
- Individual lawsuits outside the settlement program — Cases that proceed to trial or negotiate individually may achieve different results. The three bellwether trials produced jury awards ranging from $80 million to $2.055 billion (before judicial reductions), demonstrating the potential value of strong individual cases.
As of 2026, Bayer continues to resolve remaining claims while also facing new lawsuits. The company has set aside additional reserves beyond the original $10.9 billion and has explored various legal strategies, including seeking U.S. Supreme Court review of preemption arguments. New claims may still be filed by individuals who were recently diagnosed or who only recently became aware of the potential connection between their Roundup use and their cancer. If you believe you have a qualifying claim, consulting with a Roundup litigation attorney may help you understand what compensation you could pursue.
How to File a Roundup Weed Killer Lawsuit
Filing a Roundup lawsuit involves several stages, from an initial case evaluation through discovery, potential settlement negotiations, or trial. Understanding the process may help you feel more prepared as you consider your legal options. Below is a general overview of the typical steps involved in pursuing a Roundup cancer claim:
-
1
Free Case Evaluation
The process typically begins with a free, confidential consultation with a Roundup litigation attorney. During this evaluation, the attorney will review your Roundup exposure history, cancer diagnosis, medical records, and other relevant details to determine whether you may have a viable claim. Most Roundup attorneys work on a contingency fee basis, meaning you pay no upfront costs and the attorney only receives a fee if they recover compensation on your behalf.
-
2
Filing the Complaint
If your attorney determines that you have a qualifying claim, they will prepare and file a formal legal complaint on your behalf. Depending on the specifics of your case, the complaint may be filed in state court, federal court, or added to the Roundup multidistrict litigation (MDL No. 2741) pending in the U.S. District Court for the Northern District of California.
-
3
Discovery and Investigation
During the discovery phase, both sides exchange evidence and information relevant to the case. Your attorney will gather medical records, employment records, purchase receipts or other documentation of Roundup use, and expert testimony. The defendant may depose you and request additional documentation. This phase is critical for building the strongest possible case.
-
4
Settlement Negotiation or Trial
Many Roundup cases are resolved through settlement negotiations without going to trial. Your attorney will negotiate with Bayer or its legal representatives to seek fair compensation based on the strength of your evidence and the severity of your damages. If a satisfactory settlement cannot be reached, your case may proceed to trial, where a jury will determine liability and damages. The timeline from filing to resolution varies but may take anywhere from several months to a few years depending on the complexity of your case and the court's schedule.
Types of Compensation Available in Roundup Cases
Individuals who file a Roundup weed killer lawsuit may be able to recover several categories of damages, depending on the facts and circumstances of their case. While every claim is different and no specific outcome can be guaranteed, the following types of compensation are commonly pursued in Roundup cancer litigation:
- Medical Expenses — Compensation for past and future costs of cancer treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, prescription medications, diagnostic testing, hospital stays, rehabilitation, and ongoing monitoring. Cancer treatment costs can be substantial, and a successful claim may help recover these expenses.
- Lost Wages and Earning Capacity — Recovery for income lost due to time away from work during treatment, as well as diminished future earning capacity if your cancer diagnosis has affected your ability to work in your previous occupation or at all.
- Pain and Suffering — Damages for the physical pain, emotional distress, anxiety, depression, and diminished quality of life associated with a cancer diagnosis and treatment. These non-economic damages often represent a significant portion of total compensation in cancer cases.
- Loss of Consortium — Compensation for the impact of your illness on your relationship with your spouse or partner, including loss of companionship, affection, and support.
- Punitive Damages — In cases where the defendant's conduct is found to be particularly egregious or reckless, courts may award punitive damages intended to punish the wrongdoer and deter similar conduct. Several Roundup jury verdicts have included substantial punitive damage awards based on evidence that Monsanto knew of glyphosate's cancer risks and failed to adequately warn consumers.
- Wrongful Death Damages — If a family member died from a cancer linked to Roundup exposure, surviving family members may seek compensation for funeral and burial expenses, loss of financial support, loss of parental guidance, and other damages through a wrongful death claim.
Why You Should Act Now on Your Roundup Claim
If you believe you may have a Roundup weed killer claim, there are several important reasons to take action sooner rather than later. Delays in pursuing legal action could jeopardize your ability to recover the compensation you may deserve.
Statute of Limitations Deadlines: Every state imposes a deadline for filing personal injury and wrongful death lawsuits. These statutes of limitations typically range from two to four years, though the specific timeframe and triggering date vary by state. Missing the applicable deadline could permanently bar you from filing a claim, regardless of the strength of your case. Because statute of limitations rules can be complex — especially in cases involving latent diseases like cancer — consulting with an attorney as soon as possible is the best way to protect your rights.
Preserving Evidence: Over time, critical evidence may become more difficult to obtain. Medical records, employment records, receipts for Roundup purchases, and witness testimony are all important to building a strong case. Acting promptly helps ensure that this evidence is preserved and available for your legal team.
Ongoing Settlement Programs: Bayer's settlement programs have resolved tens of thousands of claims, but the terms and availability of settlement options may change over time. Filing your claim while active settlement mechanisms are in place could potentially lead to a more efficient resolution. Additionally, Bayer has signaled its intent to limit future liability exposure through various legal and corporate strategies, making timely action important.
No Upfront Cost: Roundup attorneys typically handle cases on a contingency fee basis. This means you pay nothing out of pocket to have your case evaluated and pursued. Attorney fees are only collected if your case results in a recovery. There is no financial risk to you in exploring your legal options, and a free consultation can help you understand whether you have a viable claim worth pursuing.